Results 231 to 240 of about 116,518 (256)

Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): Early results of RTOG 0132/ACRIN 6665†

Journal of Surgical Oncology, 2009
Margaret von Mehren, George D Demetri, Charles D Blanke   +2 more
exaly  

Getting the gist of a schwannoma

Gastrointestinal Endoscopy, 2020
Rishabh Gulati, Joshua A. Hanson, Gulshan Parasher, Daniel Castresana   +3 more
openaire   +2 more sources

GiST

2009
openaire   +2 more sources

Clinical Diagnosis of Gastrointestinal Stromal Tumor (GIST): From the Molecular Genetic Point of View

Cancers, 2019
Chiao-En Wu, Chun-Nan Yeh, Shang-Yu Wang
exaly  

Heterogeneity of kinase inhibitor resistance mechanisms in GIST†

Journal of Pathology, 2008
Michael C. Heinrich, J A Fletcher, C L Corless   +2 more
exaly  

A nonrandom association of gastrointestinal stromal tumor (GIST) and desmoid tumor (deep fibromatosis): case series of 28 patients

Annals of Oncology, 2012
David Goldstein, Alessandro Gronchi, Alexander J. Lazar   +2 more
exaly  

The Gist of It

2012
Neil Fligstein, Doug McAdam
openaire   +1 more source

Transcriptome sequencing identifies ETV6–NTRK3 as a gene fusion involved in GIST

Journal of Pathology, 2016
Sabrina Rossi, Angelo Paolo Dei Tos, Dominga Racanelli   +2 more
exaly  

A great majority of GISTs with PDGFRA mutations represent gastric tumors of low or no malignant potential

Laboratory Investigation, 2004
Agnieszka Dansonka-Mieszkowska, Markku Miettinen, Jerzy Lasota   +2 more
exaly  

A multicenter phase II study of pazopanib in patients with advanced gastrointestinal stromal tumors (GIST) following failure of at least imatinib and sunitinib

Annals of Oncology, 2014
Aya Kamaya, G D Demetri, A J Wagner
exaly